Needle-free drug delivery

Sonora, the Medicsen wearable

The injection, without the needlefor diabetesfor osteoporosisfor obesityfor autoimmune diseasesfor growth disordersfor chronic injections

Sonora is a small wearable that uses ultrasound to deliver, through intact skin, the drugs patients inject today.

Investigational device · first-in-human study completed in 2026

A syringe needle
Why does it matter? 16billion

injections a year. Every one of them, a needle.

Nobody likes needles, so people stop taking treatments that work. We founded Medicsen in 2015 after a young girl with diabetes refused to keep injecting insulin.

<35%of patients continue GLP‑1 treatment after one year.
>1Mneedle-stick injuries a year in the EU alone.
Sonora worn on the abdomen at home

The answer

Worn on the skin.Not injected.

  • Nothing pierces the skinNo needle and no cannula. Ultrasound carries the drug across.
  • You wear itOn the arm or the abdomen, at home, under your clothes.
  • You keep itOne reusable device. Only the drug cartridge changes.

How it works · ultrasound

Open.

Ultrasound makes the outer layer of the skin briefly permeable.

Deliver.

The drug crosses the skin. No needle, no cannula.

Close.

When the ultrasound stops, the skin barrier recovers.

Sonora releasing a blue dye into a gel block

Three parts

A device you keep. A cartridge you change.

A reusable body, a rechargeable pulse unit and one cartridge per drug.

It clicks together

Load the dose. Nothing sharp to handle.

The drug comes in the cartridge. No syringe to fill and no needle to throw away.

You wear it

Stick it on. Get on with your day.

5 × 3 × 1.4 cm on the arm or the abdomen, with a battery designed for 72 hours.

The dose crosses

The dose goes in. The needle never does.

Ultrasound opens the way, the drug crosses, and the skin closes again.

The invention

The hard part: an ultrasound generator small enough to wear.

Patent EP3909508B1 granted in the EU, US, China, Japan and Israel, plus trade secret on the emission parameters.

Size and battery life are design targets. Sonora is an investigational device.

The Medicsen ultrasound transducer, a titanium disc
−90%size and power vs. marketed transducers
100+designs built and tested since 2015
2.5cmtitanium-encapsulated transducer

The platform

One device. Many medicines.

Only the cartridge changes. The same device is designed for small peptides and for large antibodies.

The Sonora body with three drug cartridges

Insulin

Tested in animalsDiabetes

Teriparatide

Tested in humansOsteoporosis

GLP‑1

Tested in the labDiabetes and obesity

Antibodies

Tested in the labLarge biologic drugs
A clinical research unit with Sonora on the tray

Does it work?

Proven in animals. Safe in humans.

Three studies in animals and one in people. In every one, without ultrasound no drug crossed the skin.

0serious eventsin the first study in people, January 2026
6/6volunteers completedwith no pain or itching reported
24volunteers in Stage IIstarts late 2026 · results expected Q2 2027
2024 · In animals

Insulin, in animals

First proof that the drug reaches the blood through intact skin.

12pigs
2025 · In animals

Teriparatide, under GLP

Comparable drug levels, adjusted to delivered volume, and the same time to peak as the injection pen: 39 vs 37 minutes.

15pigs
Jan 2026 · In humans

First in humans

All six volunteers completed the study. No serious events, no pain or itching reported.

6/6volunteers
May 2026 · In animals

The refined device

Reproducible absorption with the configuration that goes into the next human study.

18pigs
Q2 2027 · Next step

Next: drug levels in humans

Head to head with the injection pen. Results expected.

24volunteers
Medicsen at Advance QueenslandMedicsen at AmgenMedicsen at Comunidad de MadridMedicsen at CPHIMedicsen at EIT HealthMedicsen at GE HealthcareMedicsen at GENMedicsen at HIWCMedicsen at InnolabsMedicsen at K-StartupMedicsen at LillyMedicsen at MapfreMedicsen at MedinovMedicsen at MIT Technology ReviewMedicsen at QIAMedicsen at SanitasMedicsen at South SummitMedicsen at UPM

Who backs us

Ten years, more than 50 awards.

Advance QueenslandHotDesq · Round 2 · 2017
AmgenM2D2 $200K Challenge · 2023Comunidad de MadridPremio Emprendedores madri+d · 2020
CPHI Pharma AwardsMost innovative drug delivery device · 2023
EIT HealthBridgehead programme · 2019
GE HealthcareHealth Venture Lab winner · 2019
Global Entrepreneurship NetworkGlobal Entrepreneurship Network · 2023
Healthcare Innovation World Cup1st place · Healthcare Innovation World Cup · 2019
InnolabsBarcelona · 2nd prize · 2017
K-Startup Grand ChallengeK-Startup Grand Challenge · 2020
Lilly & UnLtdEmprende inHealth · 2016Fundación MAPFRESocial Innovation Awards · winner · 2021Medi'nov ConnectionMedi'nov Connection · 2025
MIT Technology ReviewSpanish innovation of the year · 2017
Quality Innovation AwardsQuality innovation awards 2021SanitasSanitas Disruptive · finalist · 2018South SummitMost Innovative Winner · 2020UPMactúaupm · 2nd prize · 20161 / 18
Sonora held in the palm of a hand

Contact

Fewer needles,
less waste, less pain.

I am writing as

Patients, doctors, pharma companies, hospitals, researchers and people who want to build it with us.

European Innovation Council · Funded by the European Union
3DEXPERIENCE LabCDTI · Cervera programme (Spain)NextGenerationEURecovery, Transformation and Resilience Plan (Spain)
EIT HealthUK Research and InnovationPARP · BRINC Poland programme, with European structural funds

Este proyecto está financiado por el CDTI (Centro para el desarrollo tecnológico Industrial), a través del Ministerio de Ciencia e Innovación, en el marco de ayudas destinadas a Centros Tecnológicos de Excelencia Cervera. IDI-20210087. MÁS INFORMACIÓN

About the EU-funded project